New Recommendations for Use of 15-Valent and 20-Valent Pneumococcal Conjugant Vaccine, 2022

What is already known about this topic? Currently, the 13-valent pneumococcal conjugate vaccine (PCV) (PCV13) and the 23-valent pneumococcal polysaccharide vaccine (PPSV23) are recommended for U.S. adults. Recommendations vary by age and risk groups. What is added by this report? On October 20, 2021, the Advisory Committee on Immunization Practices recommended 15-valent PCV (PCV15) or […]

CDC warns about rise in serious pneumococcal disease. CDC said today that is is seeing a spike in serious pneumococcal disease, particularly in younger patients.  Anne Schuchat, MD, DIrector of the CDC’s National Center for Immunization and Respiratory Diseases, told reporters that the CDC is seeing an increasing number of invasive pneumococcal disease cases around […]